Department of Health and Human Services (DHHS), National Institutes of Health (NIH), and National Cancer Institute (NCI) seek to obtain OMB approval to extend the generic clearance to collect qualitative feedback on our service delivery for an additional three (3) years.
This information collection activity has garnered qualitative customer and stakeholder feedback in an efficient, timely manner, to address the Administrationâs commitment to improving service delivery. This generic has provided information about the National Cancer Instituteâs customer or stakeholder perceptions, experiences, and expectations, provided an early warning of service issues or focused attention on areas where communication, training, or operations changes might improve product or service delivery. It has also allowed feedback to contribute directly to the improvement of program management. Feedback collected under this generic clearance provides helpful information but does not yield data that can be generalized to the overall population.
EO: EO 12862 Name/Subject of EO: SETTING CUSTOMER SERVICE STANDARDS
On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control number;
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
Attachment 2 - List of Approved Sub-Studies 2025.xlsx
Attachment 1 - Fast Track Template 03.04.2026.docx
30day 0642.pdf